Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
AbbVie Completes Acquisition of Capstan Therapeutics
08:55am, Tuesday, 19'th Aug 2025
Acquisition adds a potential first-in-class in vivo targeted lipid nanoparticle (tLNP) anti-CD19 CAR-T therapy candidate for B cell-mediated autoimmune diseases as well as a proprietary tLNP platform
SkinMedica® Unveils Its Newest Hydration Hero
08:00am, Tuesday, 19'th Aug 2025
By the makers of BOTOX® Cosmetic (onabotulinumtoxinA), SkinMedica® introduces a next generation amino acid–based cleanser: HA5® Hydra Collagen Hydrating Foaming Cleanser. IRVINE, Calif , Aug. 19
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
10:01am, Monday, 18'th Aug 2025
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
If You'd Invested $1,000 in AbbVie Stock 10 Years Ago, Here's How Much You'd Have Today
05:59am, Monday, 18'th Aug 2025
AbbVie (ABBV 0.98%) became a stand-alone, publicly traded company when it split from its former parent, Abbott Laboratories, in 2013. The reason for the split was for each company to generate greater
3 Dividend Stocks to Double Up On Right Now
04:53am, Friday, 15'th Aug 2025
Inflation isn't soaring as much as expected. More interest rate cuts could be on the way from the Federal Reserve.
My Dividend Stock Portfolio: New July Dividend Record - 100 Holdings With 12 Buys
08:15am, Wednesday, 13'th Aug 2025
July saw strong market gains, especially in tech, but finding bargains is tough as indices approach all-time highs. I focused July investments on high-yield BDCs like OBDC, MFIC, and BXSL, maintaining
AbbVie: H1 2025 Earnings Strengthen Case For Targeting Gilgamesh Acquisition
04:59pm, Tuesday, 12'th Aug 2025
AbbVie Inc.'s Q2 2025 results highlight Skyrizi and Rinvoq's dominance, replacing Humira and driving impressive revenue growth, with both drugs exceeding expectations. The company's aggressive neurosc
AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.
01:00pm, Tuesday, 12'th Aug 2025
New $195 million facility will further enhance AbbVie's active pharmaceutical ingredient (API) production capacity and capabilities in the U.S. Expansion is part of AbbVie's previously announced com
My 3 Favorite Stocks to Buy Right Now
10:00am, Sunday, 10'th Aug 2025
Short-term market fluctuations can be stressful, there's no doubt about that. The good news is, long-term investors are in a better position to weather these storms.
4 Overlooked Dividend Aristocrat Stocks with Up To 60%+ Growth Potential
07:07am, Sunday, 10'th Aug 2025
Dividend Aristocrat stocks are a select group of 69 stocks that have an unbroken track record of at least 25 consecutive years of dividend increases.
3 Stocks Retirees Should Absolutely Love
06:45am, Saturday, 09'th Aug 2025
Priorities change as you enter new seasons of life. That's especially true for your retirement years.
Dividend Champion, Contender, And Challenger Highlights: Week Of August 10
06:07pm, Friday, 08'th Aug 2025
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79%
01:23pm, Friday, 08'th Aug 2025
Genmab A/S GMAB released results Thursday of the Phase 3 EPCORE FL-1 trial evaluating subcutaneous epcoritamab in combination with rituximab and lenalidomide (R2) versus R2 alone for adult patients wi
Get Ready, JUVÉDERM® Day is Calling!
08:00am, Wednesday, 06'th Aug 2025
Allergan Aesthetics Celebrates Third Annual JUVÉDERM® Day with BOGO Gift Cards and $10,000 Sweepstakes Join Allē Today to Take Advantage of Limited-Time Offers, While Supplies Last IRVINE, Calif. ,
Jim Cramer Says To Buy These 3 Dividend Stocks ASAP
12:52pm, Tuesday, 05'th Aug 2025
Jim Cramer likes these dividend stocks for 2025. All three dividend stocks are solid financially and pay good yields.
